Skip to main content
. 2003 Apr;55(4):389–397. doi: 10.1046/j.1365-2125.2003.01769.x

Table 3.

Serum total cholesterol concentrations in respondents treated with lipid-lowering drugs, corrected for within-person variability.

Serum total cholesterol Primary prevention (n = 294) Secondary prevention (n = 136) Total (n = 430)
≤ 5.00 mmol l−1  36 (12.2%) 47 (34.6%)  83 (19.3%)
5.01–6.50 mmol l−1 164 (55.8%) 69 (50.7%) 233 (54.2%)
6.51–8.00 mmol l−1  84 (28.6%) 15 (11.0%)  99 (23.0%)
> 8.00 mmol l−1  10 (3.4%)  5 (3.7%)  15 (3.5%)